Vanguard Group
XTNT icon

Vanguard Group’s Xtant Medical Holdings XTNT Stock Holding History

Vanguard Group’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.78M Sell
2,272,591
-83,080
-4% -$60.4K ﹤0.01% 3596
2025
Q3 		$1.53M Buy
2,355,671
+104,159
+5% +$65.7K ﹤0.01% 3659
2025
Q2 		$1.66M Hold
2,251,512
– – ﹤0.01% 3594
2025
Q1 		$1.06M Buy
2,251,512
+100,600
+5% +$53K ﹤0.01% 3695
2024
Q4 		$953K Hold
2,150,912
– – ﹤0.01% 3779
2024
Q3 		$1.45M Hold
2,150,912
– – ﹤0.01% 3657
2024
Q2 		$1.36M Buy
2,150,912
+602,600
+39% +$481K ﹤0.01% 3692
2024
Q1 		$1.81M Buy
1,548,312
+48,319
+3% +$53K ﹤0.01% 3623
2023
Q4 		$1.69M Buy
1,499,993
+14,653
+1% +$17.2K ﹤0.01% 3659
2023
Q3 		$1.63M Buy
1,485,340
+206,288
+16% +$221K ﹤0.01% 3652
2023
Q2 		$1.19M Hold
1,279,052
– – ﹤0.01% 3848
2023
Q1 		$815K Buy
1,279,052
+100
+0% +$73 ﹤0.01% 3983
2022
Q4 		$844K Buy
1,278,952
+161,042
+14% +$105K ﹤0.01% 3963
2022
Q3 		$805K Buy
+1,117,910
New +$612K ﹤0.01% 4067
2022
Q1 		– Sell
-44,170
Closed -$25K – 4655
2021
Q4 		$25K Sell
44,170
-4,066
-8% -$3.83K ﹤0.01% 4630
2021
Q3 		$54K Buy
48,236
+4,066
+9% +$5.29K ﹤0.01% 4541
2021
Q2 		$72K Hold
44,170
– – ﹤0.01% 4415
2021
Q1 		$104K Hold
44,170
– – ﹤0.01% 4318
2020
Q4 		$53K Sell
44,170
-32,068
-42% -$41.3K ﹤0.01% 4178
2020
Q3 		$63K Sell
76,238
-196,232
-72% -$192K ﹤0.01% 4051
2020
Q2 		$245K Sell
272,470
-10,399
-4% -$9.54K ﹤0.01% 3899
2020
Q1 		$189K Hold
282,869
– – ﹤0.01% 3870
2019
Q4 		$453K Hold
282,869
– – ﹤0.01% 3817
2019
Q3 		$803K Sell
282,869
-1,366
-0.5% -$3.79K ﹤0.01% 3704
2019
Q2 		$853K Sell
284,235
-5,017
-2% -$15.4K ﹤0.01% 3719
2019
Q1 		$882K Sell
289,252
-48,312
-14% -$141K ﹤0.01% 3661
2018
Q4 		$543K Sell
337,564
-30,541
-8% -$98.5K ﹤0.01% 3722
2018
Q3 		$1.42M Sell
368,105
-1,000
-0.3% -$5.29K ﹤0.01% 3628
2018
Q2 		$2.05M Buy
369,105
+353,321
+2,238% +$2.36M ﹤0.01% 3493
2018
Q1 		$125K Buy
15,784
+10,938
+226% +$72K ﹤0.01% 4014
2017
Q4 		$33K Sell
4,846
-92
-2% -$725 ﹤0.01% 4042
2017
Q3 		$43K Sell
4,938
-133
-3% -$1.19K ﹤0.01% 4036
2017
Q2 		$41K Buy
5,071
+1,255
+33% +$8.35K ﹤0.01% 4036
2017
Q1 		$29K Buy
3,816
+865
+29% +$5.32K ﹤0.01% 4047
2016
Q4 		$20K Buy
2,951
+1,426
+94% +$12.3K ﹤0.01% 4069
2016
Q3 		$20K Buy
+1,525
New +$28.1K ﹤0.01% 4072
2015
Q2 		– Sell
-12,243
Closed -$602K – 4200
2015
Q1 		$602K Hold
12,243
– – ﹤0.01% 3776
2014
Q4 		$445K Hold
12,243
– – ﹤0.01% 3769
2014
Q3 		$658K Buy
12,243
+4,286
+54% +$285K ﹤0.01% 3637
2014
Q2 		$644K Buy
7,957
+1,553
+24% +$132K ﹤0.01% 3615
2014
Q1 		$645K Buy
6,404
+1,466
+30% +$116K ﹤0.01% 3585
2013
Q4 		$296K Hold
4,938
– – ﹤0.01% 3709
2013
Q3 		$397K Buy
4,938
+53
+1% +$3.81K ﹤0.01% 3588
2013
Q2 		$264K Buy
+4,885
New +$404K ﹤0.01% 3603

Other funds holding XTNT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group's XTNT Position: Q4 2025 in Review

Vanguard Group reduced its Xtant Medical Holdings (XTNT) stake by 3.5% in Q4 2025, selling an estimated $60.4K and leaving 2,272,591 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #3596.

Vanguard Group first reported a position in XTNT in Q2 2013 and has held it in 44 quarters since. The position peaked at $2.05M in Q2 2018. 35 funds tracked by Wall St. Rank hold XTNT as of Q4 2025.

  • Vanguard Group held 2,272,591 shares of Xtant Medical Holdings worth $1.78M as of Q4 2025.
  • Vanguard Group sold 83,080 Xtant Medical Holdings shares in Q4 2025, an estimated $60.4K.
  • Xtant Medical Holdings made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3596 holding.
  • Vanguard Group first reported a position in Xtant Medical Holdings in Q2 2013 and has held it in 44 quarters since.
  • Vanguard Group's Xtant Medical Holdings position peaked at $2.05M in Q2 2018.
  • 35 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.